. 2023; 40(2): 101-117 | DOI: 10.4274/tjh.galenos.2023.2022-0339 | |||
ENOX2 NADH Oksidaz: Kronik Myeloid Lösemi’de Hücre Dışına Salgılanan ve BCR-ABL1- Bağımlı Hücre Yüzeyi Redoks ProteiniSeda Baykal1, Maud Voldoire2, Christophe Desterke3, Nathalie Sorel4, Emilie Cayssials5, Hyacinthe Johnson Ansah6, Agnes Guerci Bresler7, Annelise Bennaceur Griscelli8, Jean Claude Chomel9, Ali G. Turhan101İzmir Biomedicine and Genome Center, İzmir, Türkiye; Dokuz Eylül University Faculty of Medicine, Department of Medical Biology, İzmir, Türkiye2CHD La Roche-sur-Yon-Service de Médecine Onco-Hématologie, La Roche-sur-Yon, Pays de la Loire, France 3Université Paris-Saclay BU Kremlin-Bicêtre-Faculté de Médecine, Le Kremlin-Bicetre, Île-de-France 4CHU Poitiers-Service de Cancérologie Biologique, Poitiers, France 5CHU Poitiers-Service d’Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France 6CHRU de Caen-Service d'Hématologie Clinique, Caen, Basse-Normandie, France 7Hôpital Brabois-Service d'Hématologie Clinique, Vandoeuvre les Nancy, France 8AP-HP Université Paris Saclay-Service d’Hématologie, Le Kremlin-Bicetre, Île-de-France, France 9INSERM-UA9, Villejuif, Paris, Île-de-France, France 10Paris-Saclay University-Service d'hematologie, Hopital Bicetre, Paris, Villejuif, France Amaç: Kronik myeloid lösemi (KML), hematopoietik kök hücrelerde BCR-ABL1 füzyon geninin ortaya çıkması ile oluşan bir hastalıktır. Bu çalışmada, KML’de potansiyel bir salgılanabilir biyobelirteç olan onkogen fetal ENOX2 proteinine odaklanılmıştır. ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid LeukemiaSeda Baykal1, Maud Voldoire2, Christophe Desterke3, Nathalie Sorel4, Emilie Cayssials5, Hyacinthe Johnson Ansah6, Agnes Guerci Bresler7, Annelise Bennaceur Griscelli8, Jean Claude Chomel9, Ali G. Turhan101İzmir Biomedicine and Genome Center, İzmir, Türkiye; Dokuz Eylül University Faculty of Medicine, Department of Medical Biology, İzmir, Türkiye2CHD La Roche-sur-Yon-Service de Médecine Onco-Hématologie, La Roche-sur-Yon, Pays de la Loire, France 3Université Paris-Saclay BU Kremlin-Bicêtre-Faculté de Médecine, Le Kremlin-Bicetre, Île-de-France 4CHU Poitiers-Service de Cancérologie Biologique, Poitiers, France 5CHU Poitiers-Service d’Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France 6CHRU de Caen-Service d'Hématologie Clinique, Caen, Basse-Normandie, France 7Hôpital Brabois-Service d'Hématologie Clinique, Vandoeuvre les Nancy, France 8AP-HP Université Paris Saclay-Service d’Hématologie, Le Kremlin-Bicetre, Île-de-France, France 9INSERM-UA9, Villejuif, Paris, Île-de-France, France 10Paris-Saclay University-Service d'hematologie, Hopital Bicetre, Paris, Villejuif, France Objective: Chronic myeloid leukemia (CML) is a disease caused by the acquisition of BCR-ABL1 fusion in hematopoietic stem cells. In this study, we focus on the oncofetal ENOX2 protein as a potential secretable biomarker in CML. Seda Baykal, Maud Voldoire, Christophe Desterke, Nathalie Sorel, Emilie Cayssials, Hyacinthe Johnson Ansah, Agnes Guerci Bresler, Annelise Bennaceur Griscelli, Jean Claude Chomel, Ali G. Turhan. ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia. . 2023; 40(2): 101-117 Sorumlu Yazar: Ali G. Turhan |
|